{'52WeekChange': -0.1586613,
 'SandP52WeekChange': 0.0644362,
 'address1': 'Building 1',
 'address2': '900 Middlesex Turnpike',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 27.16,
 'askSize': 900,
 'averageDailyVolume10Day': 174625,
 'averageVolume': 179136,
 'averageVolume10days': 174625,
 'beta': 1.760043,
 'beta3Year': None,
 'bid': 26.25,
 'bidSize': 1000,
 'bookValue': 4.215,
 'category': None,
 'circulatingSupply': None,
 'city': 'Billerica',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 30,
 'dayLow': 27,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -18.807,
 'enterpriseToRevenue': 11.691,
 'enterpriseValue': 702938496,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 27.408857,
 'fiftyTwoWeekHigh': 32.82,
 'fiftyTwoWeekLow': 10.895,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 19436913,
 'forwardEps': -1.35,
 'forwardPE': -20.11111,
 'fromCurrency': None,
 'fullTimeEmployees': 248,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.09313,
 'heldPercentInstitutions': 0.86616,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/quanterix.com',
 'longBusinessSummary': 'Quanterix Corporation, a life sciences company, '
                        'develops and markets digital immunoassay platforms '
                        'that advances precision health for life sciences '
                        'research and diagnostics in North America, Europe, '
                        'the Middle East, Africa, and the Asia Pacific. The '
                        'company offers HD-X instrument, a sensitive automated '
                        'multiplex protein detection platform; and SR-X '
                        'instrument that enables researchers to apply Simoa '
                        'detection technology in various applications, '
                        'including direct detection of nucleic acids. It also '
                        'develops SP-X instrument that is based on Simoa '
                        'planar array technology for the measurement of '
                        'multiplex chemiluminescent immunoassays. The '
                        "company's products include kits, such as beads, "
                        'capture and detector reagents, enzyme reagents, and '
                        'enzyme substrates to run tests; and consumables, such '
                        'as proprietary Simoa disks, cuvettes, and disposable '
                        'tips. In addition, it offers contract research '
                        'services, including sample testing, homebrew assay '
                        'development, and custom development services. The '
                        'company primarily operates in the areas of neurology, '
                        'oncology, cardiology, infectious diseases, and '
                        'inflammation. It sell its products for the life '
                        'science research sector primarily to laboratories '
                        'associated with academic and governmental research '
                        'institutions, as well as pharmaceutical, '
                        'biotechnology, and contract research companies '
                        'through a direct sales force, support organizations, '
                        'and distributors or sales agents. The company was '
                        'formerly known as Digital Genomics, Inc. and changed '
                        'its name to Quanterix Corporation in August 2007. '
                        'Quanterix Corporation was incorporated in 2007 and is '
                        'headquartered in Billerica, Massachusetts.',
 'longName': 'Quanterix Corporation',
 'market': 'us_market',
 'marketCap': 768643648,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_47689694',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -43001000,
 'nextFiscalYearEnd': 1640908800,
 'open': 29.79,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '617 301 9400',
 'previousClose': 30.05,
 'priceHint': 2,
 'priceToBook': 6.441281,
 'priceToSalesTrailing12Months': 12.784307,
 'profitMargins': -0.71519995,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 30,
 'regularMarketDayLow': 27,
 'regularMarketOpen': 29.79,
 'regularMarketPreviousClose': 30.05,
 'regularMarketPrice': 29.79,
 'regularMarketVolume': 192743,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 28311000,
 'sharesPercentSharesOut': 0.0428,
 'sharesShort': 1210470,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1055307,
 'shortName': 'Quanterix Corporation',
 'shortPercentOfFloat': 0.0746,
 'shortRatio': 6.65,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'QTRX',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.621,
 'twoHundredDayAverage': 24.615612,
 'volume': 192743,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.quanterix.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '01821'}